Sign In
Buy LLY
$1,125.38
+42.15 (+3.89%)
At Close: Jun 04, 2026
Lilly to cut insulin prices by 70%, cap prices at $35 per month for people with private insurance
08:30am, Wednesday, 01'st Mar 2023
Drugmaker Eli Lilly & Co. on Wednesday said it will cut prices of its most commonly prescribed insulins by 70% and cap monthly prices at $35 per month at certain retail pharmacies for people who have
Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know
10:32am, Wednesday, 22'nd Feb 2023
Lilly (LLY) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Analyst Confidence in Eli Lilly Boosted by Product Pipeline
09:01am, Wednesday, 22'nd Feb 2023
Eli Lilly and Company (NYSE: LLY) is one of the most recognized names in the pharmaceutical industry. Indeed, they are the 12th-largest pharmaceutical company in the world by revenue ($5.5 billion in
3 Top Defensive Stocks to Buy Hand Over Fist Right Now
10:45am, Tuesday, 21'st Feb 2023
These three defensive stocks could cushion your portfolio from market volatility this year.
Is This Supercharged Growth Stock a Buy?
08:30am, Monday, 20'th Feb 2023
Shares of this drugmaker have trounced the S&P 500 index in the last decade.
Eli Lilly Is Still Overvalued But Should Be On Your Watchlist
04:32pm, Friday, 17'th Feb 2023
Eli Lilly and Company is a fast-growing and promising leading pharmaceutical company. Eli Lilly's shares are expensive now, trading for almost 40 times future earnings.
Eli Lilly: Mounjaro Needs To Catch Up In 2023
02:46pm, Friday, 17'th Feb 2023
The Eli Lilly and Company diabetes upstart was on fewer formularies than reported. Less coverage meant lower Eli Lilly and Company sales, contributing to a revenue miss in Q4.
Should Income Investors Buy This Dow Jones Stock?
09:15am, Friday, 17'th Feb 2023
This drugmaker boasts an impressive product portfolio and pipeline.
Top 10 Holdings of Phil Gross and Robert Atchinson
10:54pm, Thursday, 16'th Feb 2023
Phil Gross and Robert Atchinson founded Adage Capital Partners in 2001. Gross was initially a healthcare and retail analyst at the Harvard Management Company (HMC), and later became a partner at HMC.
Eli Lilly and Co (LLY) SVB Securities Global Biopharma Conference Transcript
04:25pm, Thursday, 16'th Feb 2023
Eli Lilly and Co (NYSE:LLY ) SVB Securities Global Biopharma Conference February 16, 2023 12:00 PM ET Company Participants Ilya Yuffa - SVP & President, Lilly International Conference Call Participant
Eli Lilly recruits Black patients for Alzheimer trial as drugmakers seek more diversity in clinical studies
11:02am, Thursday, 16'th Feb 2023
Retailers CVS Health, Walgreens and Kroger have announced new initiatives to provide clinical trial enrollment and follow-up services in their pharmacy clinics.
Which Healthcare Stock Is a Better Pick in 2023?
04:05pm, Tuesday, 14'th Feb 2023
Investor sentiment has improved this year on expectations of less-aggressive interest rate hikes by the Federal Reserve to tame inflation. However, the ongoing macro uncertainty continues to create co
3 Supercharged Dividend Stocks to Buy if There's a Stock Market Sell-Off
05:33am, Monday, 13'th Feb 2023
Income stocks can lend portfolio growth in both up and down markets.
3 Surefire Growth Stocks You Can Buy Right Now
02:31pm, Saturday, 11'th Feb 2023
Maybe there's no such thing as a sure thing. But these stocks could come close.
Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It
10:34am, Thursday, 09'th Feb 2023
Recently, Zacks.com users have been paying close attention to Lilly (LLY). This makes it worthwhile to examine what the stock has in store.
